MD Financial Analysis
Quarterly
FY2024Q4 | FY2024Q3 | FY2024Q2 | FY2024Q1 | FY2023Q4 | FY2023Q3 | FY2023Q2 | FY2023Q1 | FY2022Q4 | FY2022Q3 | FY2022Q2 | FY2022Q1 | FY2021Q4 | FY2021Q3 | FY2021Q2 | FY2021Q1 | FY2020Q4 | FY2020Q3 | FY2020Q2 | FY2020Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Assets | 2.15B -3.02% | 2.08B -10.72% | 2.00B -13.45% | 2.17B -6.55% | 2.22B -5.45% | 2.33B -0.24% | 2.31B -2.71% | 2.32B -0.89% | 2.35B -13.76% | 2.33B -11.87% | 2.37B -7.26% | 2.34B -5.75% | 2.72B -18.68% | 2.65B -22.74% | 2.56B -24.57% | 2.48B -42.50% | 3.35B -19.25% | 3.42B -20.18% | 3.39B -39.93% | 4.32B -24.30% |
Total Current Assets | 639.61M 32.30% | 528.22M 25.61% | 429.21M 7.91% | 426.52M 4.39% | 483.45M 12.96% | 420.52M -0.75% | 397.77M -13.40% | 408.59M -7.09% | 427.99M -49.08% | 423.71M -46.23% | 459.30M -38.95% | 439.78M -33.91% | 840.56M -45.75% | 788.03M -52.27% | 752.31M 9.30% | 665.40M -29.28% | 1.55B 111.80% | 1.65B 71.05% | 688.33M -30.16% | 940.90M -11.02% |
Total Non-Current Assets | 1.51B -12.86% | 1.55B -18.74% | 1.57B -17.91% | 1.74B -8.88% | 1.74B -9.56% | 1.91B -0.13% | 1.91B -0.13% | 1.91B 0.54% | 1.92B 2.01% | 1.91B 2.70% | 1.91B 5.96% | 1.90B 4.56% | 1.88B 4.64% | 1.86B 4.76% | 1.80B -33.20% | 1.82B -46.18% | 1.80B -47.32% | 1.77B -46.66% | 2.70B -42.00% | 3.38B -27.32% |
Total Liabilities | 1.39B 1.24% | 1.34B -1.03% | 1.29B -5.45% | 1.31B -6.97% | 1.37B -5.87% | 1.36B -7.80% | 1.36B -10.57% | 1.41B -3.66% | 1.46B -20.24% | 1.47B -18.17% | 1.52B -12.70% | 1.46B -14.73% | 1.83B -29.78% | 1.80B -31.28% | 1.75B -31.81% | 1.72B -39.39% | 2.60B -1.76% | 2.62B -6.81% | 2.56B -12.12% | 2.83B -3.22% |
Total Current Liabilities | 434.11M 11.61% | 373.08M 6.46% | 310.16M -3.17% | 247.28M -13.00% | 388.95M -8.91% | 350.44M -0.36% | 320.32M -2.76% | 284.22M 5.37% | 426.98M -0.09% | 351.69M -11.54% | 329.42M -6.18% | 269.73M -17.50% | 427.37M -3.82% | 397.56M -18.59% | 351.11M -8.55% | 326.96M -5.61% | 444.34M -17.99% | 488.36M -2.48% | 383.93M -12.95% | 346.40M -16.57% |
Total Non-Current Liabilities | 953.65M -2.87% | 971.30M -3.63% | 978.73M -6.15% | 1.06B -5.45% | 981.80M -4.61% | 1.01B -10.14% | 1.04B -12.72% | 1.13B -5.70% | 1.03B -26.40% | 1.12B -20.05% | 1.19B -14.35% | 1.19B -14.08% | 1.40B -35.13% | 1.40B -34.18% | 1.39B -35.92% | 1.39B -44.09% | 2.16B 2.41% | 2.13B -7.75% | 2.18B -11.97% | 2.49B -1.01% |
Total Shareholders' Equity | 764.94M -9.91% | 732.49M -24.33% | 706.46M -25.03% | 856.20M -5.89% | 849.06M -4.77% | 967.99M 12.73% | 942.38M 11.47% | 909.77M 3.73% | 891.63M -0.56% | 858.67M 1.54% | 845.43M 4.49% | 877.08M 14.35% | 896.69M 19.92% | 845.68M 5.05% | 809.12M -2.11% | 766.98M -48.43% | 747.72M -50.12% | 805.01M -45.58% | 826.57M -69.67% | 1.49B -46.49% |
Shareholders' Equity | 764.94M -9.91% | 732.49M -24.33% | 706.46M -25.03% | 856.20M -5.89% | 849.06M -4.77% | 967.99M 12.73% | 942.38M 11.47% | 909.77M 3.73% | 891.63M -0.54% | 858.67M 1.56% | 845.43M 4.52% | 877.08M 14.39% | 896.49M 19.93% | 845.47M 5.06% | 808.91M -2.14% | 766.76M -48.45% | 747.49M -50.13% | 804.76M -45.60% | 826.57M -69.67% | 1.49B -46.49% |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 -100.00% | 0.00 -100.00% | 0.00 -100.00% | 0.00 -100.00% | 205.00K -11.64% | 211.00K -13.88% | 218.00K | 224.00K | 232.00K | 245.00K | 0.00 | 0.00 |
Total Liabilities & Equity | 2.15B -3.02% | 2.08B -10.72% | 2.00B -13.45% | 2.17B -6.55% | 2.22B -5.45% | 2.33B -0.24% | 2.31B -2.71% | 2.32B -0.89% | 2.35B -13.76% | 2.33B -11.87% | 2.37B -7.26% | 2.34B -5.75% | 2.72B -18.68% | 2.65B -22.74% | 2.56B -24.57% | 2.48B -42.50% | 3.35B -19.25% | 3.42B -20.18% | 3.39B -39.93% | 4.32B -24.30% |
Net Debt | 269.16M -40.92% | 406.27M -20.64% | 497.17M -13.81% | 594.29M -9.25% | 455.59M -16.90% | 511.90M -20.74% | 576.85M -17.67% | 654.90M -7.84% | 548.22M 5.91% | 645.86M 17.72% | 700.70M 25.11% | 710.58M 13.01% | 517.64M 0.30% | 548.64M -59.91% | 560.06M -63.05% | 628.79M -63.13% | 516.09M -66.56% | 1.37B -25.30% | 1.52B -23.16% | 1.71B -15.02% |
Working Capital | 205.50M 117.44% | 155.14M 121.37% | 119.06M 53.72% | 179.24M 44.11% | 94.51M 9294.43% | 70.08M -2.68% | 77.45M -40.37% | 124.37M -26.86% | 1.01M -99.76% | 72.01M -81.56% | 129.89M -67.63% | 170.05M -49.75% | 413.20M -62.61% | 390.47M -66.42% | 401.21M 31.80% | 338.44M -43.07% | 1.11B 482.54% | 1.16B 150.33% | 304.40M -44.09% | 594.50M -7.43% |
Free Financial AI Agent for Investment
Ask any investment related question and get answer instantly
Is MD earnings result positive or negative?How should I trade on MD earnings?MD FAQs
What is MD's PE Ratio in 2025/3/28?
MD's PE ratio in March 28, 2025 is -11.90. This indicates the price investors are willing to pay for $1 of earnings.
What is MD's PS Ratio in 2025/3/28?
MD's PS ratio in March 28, 2025 is 0.63. This indicates how much investors are willing to pay for each dollar of the company's sales.
What is MD's Dividend Yield in 2024/Q4?
MD's Dividend Yield in 2024/Q4 is 0.00%. This represents the return on investment from dividends relative to the stock price.
What is MD's Gross Margin in 2024/Q4?
MD's Gross Margin in 2024/Q4 is 100.00. Gross Margin is typically calculated as (Revenue - Cost of Goods Sold) / Revenue and is a key indicator of a company's financial health and efficiency in managing production costs.
Free Financial AI Agent for Investment
Ask any investment related question and get answer instantly
Is MD earnings result positive or negative?How should I trade on MD earnings?